Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:28 AM
Ignite Modification Date:
2025-12-25 @ 3:28 AM
NCT ID:
NCT05875805
Eligibility Criteria:
Inclusion and Exclusion Criteria for Patients
Inclusion criteria:
* Age ≥60 years
* A diagnosis of AML, MDS, and similar myeloid malignancies (including but not limited to MDS/MPN overlap syndrome, myelofibrosis)
* Being managed in the outpatient settings
* Able to provide informed consent
* English-speaking
Exclusion criteria:
\- None
Inclusion and Exclusion Criteria for Caregivers
Inclusion criteria:
* Age ≥18 years
* Selected by patient when asked if there is a "family member, partner, friend, or caregiver with whom you discuss or who can be helpful in health-related matters"
* Able to provide informed consent
* English-speaking
Exclusion criteria:
\- None
Inclusion and Exclusion Criteria for Oncology Providers
Inclusion criteria:
\- Oncologists and/or APPs who will be conducting the telehealth-delivered ACP visit
Exclusion criteria:
\- None
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
60 Years
Study:
NCT05875805
Study Brief:
Protocol Section:
NCT05875805